Zydus Lifesciences Q4 profit declines 41% to Rs 397 cr - Economic Times

The company also incurred expenses of Rs 120 crore during the quarter for changes in inventories of finished goods, work-in-progress and stock-in-trade.

Pharmaceuticals firm Zydus Lifesciences Ltd on Friday reported a 41.47 per cent decline in consolidated net profit at Rs 397.4 crore in the fourth quarter ended March, impacted by higher expenses and… [+2615 chars]

full article...